ST266 Eye Drops

· Noveome Biotherapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ST266 Eye Drops, covering 2021-08-18 to 2021-08-18. Get the full timeline:

Most recent: Clinical Trial Update: ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects [Phase 2]